We’re living the COVID comeback, but the immunocompromised among us may still need to wear mask. We need to show kindness, not indignation.

Mark Cuban's latest venture may shift people's perception on the drug supply chain. That's a welcome opportunity to rethink it.

The very latest official CBO report now states unequivocally: It's "unlikely" drug net prices have increased, and they declined in Medicare

The majority of "drug spending" isn't really on drugs. When it comes to overall spending on pharmaceuticals, only 37% go to manufacturers.

Per CMS: Drug prices are not skyrocketing on the list price level and they are in fact declining for yet another year on net prices.